Centennial Partners

Partner About Website Address
Aspa Therapeutics Aspa Therapeutics is working to develop a safe and effective gene therapy for patients with Canavan disease, a rare condition caused by an inherited mutation of the ASPA gene. Partner Site Partners II
Adrenas Therapeutics Inc. Adrenas Therapeutics is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. Partner Site Partners II
Benanova Inc.

Benanova Inc. has developed a cost-efficient, environmentally benign particle system (EbNPs) made of natural materials, which can leverage the functional properties of bioactive agents. This innovative, patent-pending technology can facilitate the development of highly efficient, application-customized and environmentally benign replacements for silver nanoparticle antimicrobials.

Partner Site Partners II